Granules Pharmaceuticals Inc.
Chantilly, VA, United States
This page shows every FDA and USDA recall linked to Granules Pharmaceuticals Inc.. Each entry includes the product involved, when the recall happened, and how serious it was. If a company has had multiple recalls over the years, you can see the full history here in one place — including whether any were Class I, which is the most serious type.
7
Total Recalls
2020
First Recall
2026
Most Recent
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyder...
Feb 11, 2026
· Drug
Class II
Ongoing
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sul...
Oct 1, 2025
· Drug
Class III
Ongoing
Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01;...
Jul 9, 2025
· Drug
Class II
Ongoing
Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantill...
Jan 15, 2025
· Drug
Class II
Terminated
Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 1000-count bottles, Rx Only, Manufactured by: G...
Jan 15, 2025
· Drug
Class II
Terminated
Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only, Manufactured by: Granules India Limited Hyderabad...
Aug 14, 2024
· Drug
Class II
Terminated
Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, a) 100 ct. bottle (NDC 70010-492-01) and 500 ct....
Jul 22, 2020
· Drug
Class II
Ongoing